The analysis of lung cancer patients (LCP) survival during one-year period after diagnosing of disease Source: Eur Respir J 2006; 28: Suppl. 50, 88s Year: 2006
Different mortality, recurrence and bleeding between cancer and non cancer patients with pulmonary embolism (PE): 1 year follow-up. Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017
Follow-up and surveillance for lung cancer Source: Annual Congress 2005 - MP5 - Follow-up and surveillance for lung cancer Year: 2005
Outcome of patients discharged from rapid access lung clinic (RALC) with non cancer diagnosis: Five year follow up Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
Four years follow-up of exacerbations in a cohort of COPD patients: 1 year interim results (EXACO study) Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008
Survival trend of patients with lung cancer (LC) in Cáceres (Spain) (1991-2003). Analysis based on TNM staging, histology, modality-treatment and time-period of diagnosis Source: Eur Respir J 2007; 30: Suppl. 51, 669s Year: 2007
Bronchoscopy - any use for follow-up of operated lung cancer (LC) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 17s Year: 2001
Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT). Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Long-term survivors in stage IIIB/IV lung cancer – a 5 year retrospective analysis Source: Eur Respir J 2007; 30: Suppl. 51, 432s Year: 2007
Sleeve-pneumonectomy for lung cancer – survival and complications (update 2005) Source: Eur Respir J 2005; 26: Suppl. 49, 492s Year: 2005
Rates of treatment response and median survival in advanced non small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 302s Year: 2004
Analysis of lung adenocarcinoma in patients aged 70 and over: The viewpoint of clinical stage, therapeutic modality and prognosis Source: Eur Respir J 2002; 20: Suppl. 38, 269s Year: 2002
The effect on disease free survival of different regimens of chemotherapy (CT) in non small cell lung cancer (NSCLC) Source: Eur Respir J 2004; 24: Suppl. 48, 672s Year: 2004
The analysis of cell type and age patern in lung cancer patients within six years Source: Eur Respir J 2006; 28: Suppl. 50, 92s Year: 2006
Neoplastic pericardial involvement as a first sign of lung cancer - diagnosis and treatment. An analysis of 33 patients treated in ICU Source: Eur Respir J 2002; 20: Suppl. 38, 76s Year: 2002
Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC) Source: International Congress 2019 – Treatment of lung cancer Year: 2019
Unsuspected N2 disease: A retrospective analysis comparing survival in patients with suspected N2 disease in non-small cell lung cancer Source: International Congress 2017 – Thoracic surgery Year: 2017
The prognosis of childhood asthma, 10 year follow-up Source: Eur Respir J 2005; 26: Suppl. 49, 452s Year: 2005
Time to diagnosis and time to therapy in patients with malignant pleural mesothelioma (MPM) compared to patients with lung cancer in Denmark 2007 to 2011. A quality assurance analysis Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012